Huret B, Perez T, Dhalluin X, Dewavrin F, Ramon P-P, Fournier C
Service d'endoscopie respiratoire, pôle des maladies respiratoires, hôpital Calmette, CHRU de Lille, 59000 Lille, France.
Service d'explorations fonctionnelles respiratoires, hôpital Calmette, CHRU de Lille, 59000 Lille, France.
Rev Mal Respir. 2015 May;32(5):477-84. doi: 10.1016/j.rmr.2013.09.018. Epub 2013 Nov 9.
Endobronchial resection is now the standard treatment for tracheobronchial narrowing due to malignancy. The clinical and functional respiratory improvement has been evaluated previously but only in heterogeneous population.
Between February 2009 and February 2011, we conducted a prospective single centre study at the University Hospital of Lille. Twenty-five patients with malignant tracheobronchial stenosis received a clinical and functional respiratory evaluation before and after a rigid bronchoscopy procedure to reduce the obstruction followed where appropriate by placement of an endobronchial stent.
Thirteen patients (52%) had primary lung cancer and in 12 the tumor had another origin. Nineteen patients (76%) received a stent after bronchial unblocking. Clinically, all patients felt an improvement in their dyspnea estimated by the Borg score with a median improvement of -2 points [-1; -4] following the procedure (P<0.001). In 96% the dyspnea visual analogic scale improved by 40 mm [27; 67] (P<0.0001). The FEV1 increased significantly after unblocking by 9% [-3.5; 28.5] (P<0.05). The Rint decreased significantly by -0.19 kPa/L per second [-0.06; -0.023] (P=0.001). Correlations between scales of dyspnea and spirometric values were not significant (P>0.05). The survival rate at 1 year was 29%.
Interventional bronchoscopy decreases dyspnea. It modestly improves respiratory function and decreases the Rint. However, lung function and dyspnea scales are not correlated. No spirometry factor can predict clinical dyspnea response but an elevated Borg dyspnea scale might be a good indicator.
对于因恶性肿瘤导致的气管支气管狭窄,支气管内切除术目前是标准治疗方法。此前已对临床及呼吸功能改善情况进行过评估,但仅在异质性人群中开展。
2009年2月至2011年2月期间,我们在里尔大学医院进行了一项前瞻性单中心研究。25例恶性气管支气管狭窄患者在硬支气管镜检查以减轻梗阻之前及之后接受了临床及呼吸功能评估,必要时随后放置支气管内支架。
13例患者(52%)患有原发性肺癌,12例肿瘤有其他来源。19例患者(76%)在支气管疏通后放置了支架。临床上,所有患者的呼吸困难经Borg评分评估均有改善,术后中位数改善-2分[-1;-4](P<0.001)。96%的患者视觉模拟呼吸困难量表改善了40 mm[27;67](P<0.0001)。通气后第一秒用力呼气容积(FEV1)显著增加9%[-3.5;28.5](P<0.05)。比气道阻力(Rint)每秒显著降低-0.19 kPa/L[-0.06;-0.023](P=0.001)。呼吸困难量表与肺功能测定值之间的相关性不显著(P>0.05)。1年生存率为29%。
介入性支气管镜检查可减轻呼吸困难。它适度改善呼吸功能并降低比气道阻力。然而,肺功能与呼吸困难量表不相关。没有肺功能测定因素可预测临床呼吸困难反应,但较高的Borg呼吸困难量表评分可能是一个良好指标。